Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleTegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Where
- Ann Arbor, Atlanta, Aurora, Birmingham, Boston, Chicago, Cincinnati, Houston, Indianapolis, Los Angeles, Memphis, Minneapolis, New York, Orange, Palo Alto, Philadelphia, Pittsburgh, San Francisco, Seattle, St Louis, Washington D.C.
- Age
- 12 months to 30 years
- People
- 147
- Run by
- Children's Oncology Group
See details and how to joinNCT04851119 - Phase 3Taking peopleThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Where
- Akron, Albany, Albuquerque, Allentown, Amarillo, Anaheim, Anchorage, Ann Arbor, Arroyo Grande, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Battle Creek, Bellevue, Bellflower, Bethesda, Birmingham, Boise, Boston, Brooklyn, Burlington, Carson City, Chapel Hill, Charleston, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Durham, East Lansing, El Paso, Falls Church, Fargo, Fontana, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Greenville, Hackensack, Hartford, Henderson, Hershey, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Kingman, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Madera, Madison, Marshfield, Maywood, Memphis, Mesa, Miami, Milwaukee, Minneapolis, Morgantown, Morristown, Muskegon, Nashville, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Niles, Norfolk, Norton Shores, Oakland, Oklahoma City, Omaha, Orange, Orlando, Pahrump, Palo Alto, Paterson, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reed City, Reno, Renton, Richmond, Roanoke, Rochester, Royal Oak, Sacramento, Saint Joseph, Salt Lake City, San Antonio, San Diego, San Francisco, Scarborough, Seattle, Sioux Falls, Spokane, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Traverse City, Tucson, Valhalla, Washington D.C., Wilmington, Winfield, Winston-Salem, Wyoming, Yakima
- Age
- Up to 50 years
- People
- 62 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05235165 - Phase 3Taking peopleChemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
- Where
- Akron, Albany, Albuquerque, Allentown, Ann Arbor, Atlanta, Aurora, Austin, Baltimore, Birmingham, Boise, Boston, Buffalo, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Durham, El Paso, Falls Church, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Macon, Madera, Madison, Marshfield, Maywood, Memphis, Miami, Milwaukee, Minneapolis, Mobile, Morristown, Nashville, Neptune City, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reno, Richmond, Roanoke, Rochester, Royal Oak, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, St. Petersburg, Syracuse, Tacoma, Tampa, Temple, The Bronx, Toledo, Valhalla, Washington D.C., West Palm Beach, Wichita, Wilmington, Winfield, Winston-Salem, Worcester
- Age
- Up to 21 years
- People
- 205 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05304585 - Phase 3Taking peopleA Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Where
- Akron, Albany, Ann Arbor, Atlanta, Aurora, Austin, Baltimore, Birmingham, Boston, Buffalo, Chapel Hill, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Des Moines, Detroit, El Paso, Fargo, Fort Myers, Grand Rapids, Greenville, Hartford, Hollywood, Honolulu, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, Knoxville, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Madera, Madison, Marshfield, Miami, Milwaukee, Minneapolis, Mobile, Nashville, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oklahoma City, Omaha, Orange, Orlando, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Richmond, Rochester, Royal Oak, Sacramento, San Antonio, San Diego, San Francisco, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Valhalla, Washington D.C., Wilmington, Winston-Salem
- Age
- 4 years to 21 years
- People
- 225 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05382338 - Phase 2Taking peopleA Study to Give Treatment Inside the Eye to Treat Retinoblastoma
- Where
- Akron, Ann Arbor, Atlanta, Aurora, Austin, Birmingham, Cleveland, Dallas, Durham, Houston, Los Angeles, Memphis, Milwaukee, Palo Alto, Salt Lake City, St Louis
- Age
- Up to 18 years
- People
- 26 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05504291 - No phaseTaking peopleA Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
- Where
- Akron, Albany, Ann Arbor, Atlanta, Augusta, Austin, Baltimore, Birmingham, Buffalo, Chapel Hill, Chicago, Cleveland, Columbia, Columbus, Dallas, Dayton, Detroit, Fargo, Fort Myers, Fort Worth, Grand Rapids, Greenville, Hackensack, Hollywood, Honolulu, Houston, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Madera, Madison, Marshfield, Memphis, Milwaukee, Minneapolis, Nashville, New Haven, Oakland, Oklahoma City, Omaha, Orlando, Pensacola, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reno, Sacramento, San Antonio, San Diego, San Francisco, Seattle, Sioux Falls, Spokane, St Louis, Tampa, The Bronx, Wilmington, Winston-Salem
- Age
- 6 years to 39 years
- People
- 330 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05702645 - No phaseTaking peopleA Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
- Where
- Albany, Ann Arbor, Atlanta, Baltimore, Buffalo, Charlottesville, Cincinnati, Columbus, Duarte, Fort Myers, Fort Worth, Hackensack, Hartford, Houston, Jacksonville, Knoxville, Madera, Madison, Minneapolis, Mobile, New Haven, Orlando, Pensacola, Philadelphia, Phoenix, Pittsburgh, Portland, San Antonio, Seattle, Springfield, St Louis, Tampa, Wilmington, Winston-Salem
- Age
- 7 years and over
- People
- 190 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05705531 - Phase 1Taking peopleA Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
- Where
- Ann Arbor, Atlanta, Aurora, Birmingham, Boston, Chicago, Cincinnati, Houston, Indianapolis, Memphis, Minneapolis, New York, Orange, Philadelphia, Pittsburgh, San Francisco, Seattle, St Louis, Washington D.C.
- Age
- 1 year to 18 years
- People
- 36
- Run by
- Children's Oncology Group
See details and how to joinNCT06247787 - No phaseTaking peopleCREATE: Art for Children With Cancer
- Where
- Portland
- Age
- 8 years to 13 years
- People
- 72
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT06342453 - Phase 2Taking peopleA Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
- Where
- Albany, Ann Arbor, Atlanta, Aurora, Austin, Baltimore, Boise, Boston, Chapel Hill, Charlottesville, Chicago, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Fargo, Grand Rapids, Greenville, Hackensack, Hartford, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, Knoxville, Las Vegas, Lebanon, Little Rock, Loma Linda, Los Angeles, Louisville, Madison, Maywood, Memphis, Miami, Minneapolis, Mobile, Nashville, Newark, New Brunswick, New Haven, New Hyde Park, New York, Norfolk, Oakland, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Paterson, Pensacola, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Rochester, Salt Lake City, San Antonio, San Diego, San Francisco, Scarborough, Seattle, Sioux Falls, Spokane, St Louis, St. Petersburg, Syracuse, Tampa, The Bronx, Washington D.C., Wilmington, Winston-Salem
- Age
- 3 years to 29 years
- People
- 240 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT06368817 - Phase 3Taking peopleA Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
- Where
- Akron, Albany, Albuquerque, Amarillo, Anchorage, Ann Arbor, Atlanta, Augusta, Aurora, Austin, Baltimore, Birmingham, Boise, Boston, Buffalo, Burlington, Chapel Hill, Charlotte, Charlottesville, Chattanooga, Chicago, Cincinnati, Cleveland, Columbia, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Duarte, Durham, Falls Church, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Macon, Madera, Madison, Memphis, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Mobile, Morristown, Nashville, Neptune City, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Richmond, Roanoke, Rochester, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, Toledo, Tucson, Tulsa, Valhalla, Washington D.C., West Palm Beach, Wilmington, Winston-Salem, Worcester
- Age
- Up to 30 years
- People
- 1,656 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT06401330 - Phase 3Taking peopleTesting a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
- Where
- Albany, Ann Arbor, Atlanta, Aurora, Austin, Baltimore, Birmingham, Boston, Chapel Hill, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Dayton, Denver, Detroit, Downey, Durham, Fargo, Fort Myers, Fort Worth, Grand Rapids, Green Bay, Greenville, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Lexington, Little Rock, Loma Linda, Los Angeles, Louisville, Lubbock, Madera, Madison, Memphis, Miami, Minneapolis, Nashville, New Brunswick, New Hyde Park, New Orleans, Norfolk, Oakland, Oklahoma City, Omaha, Orlando, Paterson, Pensacola, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, Salt Lake City, San Antonio, San Francisco, Seattle, Sioux Falls, Spokane, St Louis, St. Petersburg, Tampa, The Bronx, Toledo, Tulsa, Valhalla, Washington D.C., Wilmington
- Age
- Up to 21 years
- People
- 110 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT06647953 - Phase 3Taking peopleA Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Where
- Akron, Albany, Allentown, Asheville, Atlanta, Aurora, Austin, Baltimore, Bath, Battle Creek, Birmingham, Boston, Charlottesville, Chicago, Corpus Christi, Dallas, Denver, Des Moines, Duarte, Falls Church, Fort Myers, Grand Rapids, Hartford, Hollywood, Indianapolis, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Lexington, Little Rock, Loma Linda, Los Angeles, Louisville, Madera, Madison, Milwaukee, Mobile, Muskegon, Nashville, Niles, Norfolk, Norton Shores, Oakland, Omaha, Orange, Orlando, Pensacola, Philadelphia, Pittsburgh, Portland, Providence, Reed City, Reno, Rochester, Saint Joseph, Salt Lake City, San Antonio, Sanford, Scarborough, Seattle, St Louis, St. Petersburg, Tacoma, The Bronx, Toledo, Traverse City, West Palm Beach, Wichita, Wilmington, Worcester, Wyoming
- Age
- Up to 50 years
- People
- 342 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT07466316 - Phase 1Taking peopleStudy of NXP900 With Lorlatinib in ALK+ Lung Cancer
- Where
- Fairfax
- People
- 54
- Run by
- Nuvectis Pharma, Inc.
See details and how to joinNCT07784959 - Early phase 1Taking peopleUPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
- Where
- Houston
- Age
- 1 month to 30 years
- People
- 36
- Run by
- Baylor College of Medicine
See details and how to joinNCT07059975 - Phase 2Taking peopleHaploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma
- Where
- Cincinnati
- Age
- 1 year to 39 years
- People
- 20
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT07635056 - Phase 2Not yet taking people in United StatesRAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT
- Where
- Houston
- Age
- 10 years and over
- People
- 120
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07781891 - No phaseTaking peopleMolecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- Where
- Houston
- People
- 12,000
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT01772771 - Phase 2Not yet taking people in United StatesNANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab
- Where
- Ann Arbor, Atlanta, Aurora, Boston, Chicago, Cincinnati, Dalls, Fort Worth, Los Angeles, Memphis, Philadelphia, San Francisco, Seattle
- Age
- 1 year to 30 years
- People
- 118
- Run by
- New Approaches to Neuroblastoma Therapy Consortium
See details and how to joinNCT07261241 - No phaseTaking peopleIntegration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
- Where
- Memphis
- People
- 100
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07514819 - Phase 1Taking peopleStudy of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
- Where
- Palo Alto
- Age
- 18 months to 39 years
- People
- 12
- Run by
- Laguna Biotherapeutics, Inc.
See details and how to joinNCT07573111 - Phase 1/2Taking peoplePersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Where
- Jacksonville
- Age
- 16 years and over
- People
- 138
- Run by
- Mayo Clinic
See details and how to joinNCT05269381 - Early phase 1Not yet taking people in United StatesMultiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
- Where
- Birmingham
- Age
- 10 years to 89 years
- People
- 20
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT05632562 - Early phase 1Not yet taking people in United StatesMeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
- Where
- Birmingham
- Age
- 18 months to 89 years
- People
- 28
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT05676489 - Phase 1/2Taking peopleA Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
- Where
- Cleveland, Duarte, Nashville, Santa Monica, West Valley City
- Age
- 12 years and over
- People
- 170 worldwide
- Run by
- Recursion Pharmaceuticals Inc.
See details and how to joinNCT06678659